Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system.
Sidekick is a patient-centric digital health platform that is scalable across a wide range of chronic illnesses.
Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need.
iOmx Therapeutics focuses on the development of cancer immunotherapy treatments.
Nadia Care is a maternal health company dedicated to supporting moms throughout their pregnancy and after their baby is born.
Polares medical is a medical device company with a novel device for treating mitral valve regurgitation.
Onward develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.
SNIPR Biome is a operator of a discovery stage biotech company intended to revolutionize the treatment of microbial diseases.
Nuclidium is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics.
Hilo is a healthcare company that provides blood pressure, digital therapeutics, and patient management services.
HepaRegeniX is developing drugs for treating acute and chronic liver diseases.
AMBOSS is a digital medical knowledge platform providing clinical content for decision-making.
Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research.
CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions.
SciRhom is a biotech enterprise that translate advanced scientific findings into game-changing therapies for autoimmune diseases.
Nosto is a Commerce Experience Platform offering tools to boost online revenue through end-to-end commerce experience management.
Seamless Therapeutics is reshaping the gene editing paradigm with a novel approach to restoring health in patients.
MMI is focused on advancing robotic technology for soft tissue open surgery with the world's smallest wristed instruments.
Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.
Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.
AYOXXA is a biotech company commercializing innovative technology.
#1 platform and performance app for youth footballers
IconOVir Bio is a preclinical-stage biotechnology company developing oncolytic virus therapy for the treatment of patients with cancer.
Festicket is a marketplace to discover and book music festival tickets, accommodation, transfers and extras.
Wellington Partners has invested in 59 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Wellington Partners's top investment sectors include Health Care, Medical, Biotechnology, Medical Device, Therapeutics. The firm invests across 46 different industry categories.
Among tracked funding rounds, AMBOSS received $258.9M in a Series Unknown round. Wellington Partners's total known invested capital is $2.1B.
Wellington Partners's average investment size is $41.5M across its portfolio of 59 companies.
Recent Wellington Partners portfolio additions include Tricares, Sidekick Health, Confo Therapeutics, IOmx Therapeutics, Nadia Care. These companies were founded in 2020 or later.